Omphalitis Treatment & Management
- Author: Patrick G Gallagher, MD; Chief Editor: Ted Rosenkrantz, MD more...
Treatment of omphalitis (periumbilical edema, erythema, and tenderness) in the newborn includes antimicrobial therapy and supportive care.
Note the following:
- Include parenteral antimicrobial coverage for gram-positive and gram-negative organisms. A combination of an antistaphylococcal penicillin vancomycin and an aminoglycoside antibiotic is recommended.
- Some believe that anaerobic coverage is important in all patients. Omphalitis complicated by necrotizing fasciitis or myonecrosis requires a more aggressive approach, with antimicrobial therapy directed at anaerobic organisms as well as gram-positive and gram-negative organisms. Metronidazole or clindamycin may provide anaerobic coverage.
- Pseudomonas species have been implicated in particularly rapid or invasive disease.
- As with antimicrobial therapy for other infections, consider local antibiotic susceptibility patterns, particularly patterns of S aureus and enterococcal susceptibility.
- Additional topical therapy with triple dye, bacitracin, and other antimicrobials has been suggested in addition to parenteral antibiotic therapy, but such treatment is unproven.
In addition to antimicrobial therapy, supportive care is essential to survival. These measures include the following:
- Provide ventilatory assistance and supplementary oxygen for hypoxemia or apnea unresponsive to stimulation.
- Administer fluid, vasoactive agents, or both (as indicated) for hypotension.
- Administration of platelets, fresh frozen plasma, or cryoprecipitate for disseminated intravascular coagulation (DIC) and clinical bleeding is suggested.
- Treat infants at centers capable of supporting cardiopulmonary function.
Other treatment considerations
Consider the following:
- Monitor patients for progression of disease. Early surgical intervention may be lifesaving.
- In uncomplicated cases, expect erythema of the umbilical stump to improve within 12-24 hours after the initiation of antimicrobial therapy. Failure to respond may suggest disease progression, presence of an anatomic defect, or an immunodeficiency state.
- The role of hyperbaric oxygen in treatment of patients with anaerobic necrotizing fasciitis and myonecrosis is controversial because no prospective controlled data are available and pediatric data are scarce. In the treatment chambers, tissue levels of oxygen are maximized when the patient breathes 100% oxygen at 2-3 atm. The delivery of high concentrations of oxygen to marginally perfused tissues may have a detrimental effect on the growth of anaerobic organisms and improve phagocyte function. However, surgical therapy has the highest priority, and initiation of hyperbaric oxygen therapy should not delay transport to a facility with staff capable of performing surgical debridement.
Management of necrotizing fasciitis and myonecrosis involves early and complete surgical debridement of the affected tissue and muscle.[24, 45] Consider the following:
- Although the extent of debridement depends on the viability of tissue and muscle, which is determined at the time of surgery, excision of preperitoneal tissue (including the umbilicus, umbilical vessels, and urachal remnant) is critically important in the eradication of the infection.
- These tissues can harbor invasive bacteria and provide a route for progressive spread of infection after less extensive debridement.
- Delay in diagnosis or surgery allows progression and spread of necrosis, leading to extensive tissue loss and worsening systemic toxicity.
- Several surgical procedures may be required before all nonviable tissue is removed.
The following consultations may be indicated:
- Infectious disease specialist - For appropriate antimicrobial selection, particularly if necrotizing fasciitis or myonecrosis occurs
- Surgeon - If necrotizing fasciitis or myonecrosis is suspected (consult early in the disease course)
Once omphalitis is suspected, do not feed the infant enterally. Enteral feedings may be resumed once the acute infection resolves. Parenteral nutrition is required in infants with omphalitis.
Cushing AH. Omphalitis: a review. Pediatr Infect Dis. 1985 May-Jun. 4(3):282-5. [Medline].
Airede AI. Pathogens in neonatal omphalitis. J Trop Pediatr. 1992 Jun. 38(3):129-31. [Medline].
Brook I. Microbiology of necrotizing fasciitis associated with omphalitis in the newborn infant. J Perinatol. 1998 Jan-Feb. 18(1):28-30. [Medline].
[Guideline] Riley LE, Stark AR, eds. Guidelines for Perinatal Care. 7th ed. Elk Grove Village, IL, and Wash, DC: American Academy of Pediatrics and American College of Obstetricians and Gynecologists; 2012. 302.
[Guideline] WHO. Guidelines on Maternal, Newborn, Child and Adolescent Health: Recommendations on Newborn Health. Available at http://www.who.int/maternal_child_adolescent/documents/guidelines-recommendations-newborn-health.pdf. Accessed: Sep 29 2014.
Imdad A, Bautista RM, Senen KA, et al. Umbilical cord antiseptics for preventing sepsis and death among newborns. Cochrane Database Syst Rev. 2013 May 31. 5:CD008635. [Medline].
Imdad A, Mullany LC, Baqui AH, et al. The effect of umbilical cord cleansing with chlorhexidine on omphalitis and neonatal mortality in community settings in developing countries: a meta-analysis. BMC Public Health. 2013. 13 Suppl 3:S15. [Medline]. [Full Text].
Sinha A, Sazawal S, Pradhan A, Ramji S, Opiyo N. Chlorhexidine skin or cord care for prevention of mortality and infections in neonates. Cochrane Database Syst Rev. 2015 Mar 5. 3:CD007835. [Medline].
McKenna H, Johnson D. Bacteria in neonatal omphalitis. Pathology. 1977 Apr. 9(2):111-3. [Medline].
Geil CC, Castle WK, Mortimer EA Jr. Group A streptococcal infections in newborn nurseries. Pediatrics. 1970 Dec. 46(6):849-54. [Medline].
Gezon HM, Schaberg MJ, Klein JO. Concurrent epidemics of Staphylococcus aureus and group A Streptococcus disease in a newborn nursery. Control with penicillin G and hexachlorophene bathing. Pediatrics. 1973 Feb. 51(2):383-90. [Medline].
Nelson JD, Dillon HC Jr, Howard JB. A prolonged nursery epidemic associated with a newly recognized type of group A streptococcus. J Pediatr. 1976 Nov. 89(5):792-6. [Medline].
Sawin RS, Schaller RT, Tapper D, et al. Early recognition of neonatal abdominal wall necrotizing fasciitis. Am J Surg. 1994 May. 167(5):481-4. [Medline].
Ameh EA, Nmadu PT. Major complications of omphalitis in neonates and infants. Pediatr Surg Int. 2002 Sep. 18(5-6):413-6. [Medline].
Feo CF, Dessanti A, Franco B, et al. Retroperitoneal abscess and omphalitis in young infants. Acta Paediatr. 2003. 92(1):122-5. [Medline].
Fraser N, Davies BW, Cusack J. Neonatal omphalitis: a review of its serious complications. Acta Paediatr. 2006 May. 95(5):519-22. [Medline].
Kosloske AM, Cushing AH, Borden TA, et al. Cellulitis and necrotizing fasciitis of the abdominal wall in pediatric patients. J Pediatr Surg. 1981 Jun. 16(3):246-51. [Medline].
Lally KP, Atkinson JB, Woolley MM, Mahour GH. Necrotizing fasciitis. A serious sequela of omphalitis in the newborn. Ann Surg. 1984 Jan. 199(1):101-3. [Medline].
Samuel M, Freeman NV, Vaishnav A, et al. Necrotizing fasciitis: a serious complication of omphalitis in neonates. J Pediatr Surg. 1994 Nov. 29(11):1414-6. [Medline].
Moss RL, Musemeche CA, Kosloske AM. Necrotizing fasciitis in children: prompt recognition and aggressive therapy improve survival. J Pediatr Surg. 1996 Aug. 31(8):1142-6. [Medline].
Weber DM, Freeman NV, Elhag KM. Periumbilical necrotizing fasciitis in the newborn. Eur J Pediatr Surg. 2001 Apr. 11(2):86-91. [Medline].
Nazir Z. Necrotizing fasciitis in neonates. Pediatr Surg Int. 2005 Aug. 21(8):641-4. [Medline].
Bingol-Kologlu M, Yildiz RV, Alper B, et al. Necrotizing fasciitis in children: diagnostic and therapeutic aspects. J Pediatr Surg. 2007 Nov. 42(11):1892-7. [Medline].
Mason WH, Andrews R, Ross LA, Wright HT Jr. Omphalitis in the newborn infant. Pediatr Infect Dis J. 1989 Aug. 8(8):521-5. [Medline].
O'Brien PH, Meredith HC, Vujic I, Schabel SI. Obstructive jaundice caused by cavernous transformation of the portal vein post neonatal omphalitis. J S C Med Assoc. 1979 May. 75(5):209-10. [Medline].
Perlemuter G, Bejanin H, Fritsch J, et al. Biliary obstruction caused by portal cavernoma: a study of 8 cases. J Hepatol. 1996 Jul. 25(1):58-63. [Medline].
Orloff MJ, Orloff MS, Girard B, Orloff SL. Bleeding esophagogastric varices from extrahepatic portal hypertension: 40 years' experience with portal-systemic shunt. J Am Coll Surg. 2002 Jun. 194(6):717-28; discussion 728-30. [Medline].
Hung CH, Cheng SN, Hua YM, et al. Leukocyte adhesion deficiency disorder: report of one case. Acta Paediatr Taiwan. 1999 Mar-Apr. 40(2):128-31. [Medline].
Mogica-Martinez MD, Lopez-Duran JL, Canseco-Raymundo MR, Becerril Angeles M. [Leukocyte adhesion deficiency syndrome: case report]. Rev Alerg Mex. 1999 Sep-Oct. 46(5):140-4. [Medline].
van Vliet DN, Brandsma AE, Hartwig NG. [Leukocyte-adhesion deficiency: a rare disorder of inflammation]. Ned Tijdschr Geneeskd. 2004 Dec 11. 148(50):2496-500. [Medline].
Alizadeh P, Rahbarimanesh AA, Bahram MG, Salmasian H. Leukocyte adhesion deficiency type 1 presenting as leukemoid reaction. Indian J Pediatr. 2007 Dec. 74(12):1121-3. [Medline].
Parvaneh N, Mamishi S, Rezaei A, et al. Characterization of 11 new cases of leukocyte adhesion deficiency type 1 with seven novel mutations in the ITGB2 gene. J Clin Immunol. 2010 Sep. 30(5):756-60. [Medline].
Hagimoto R, Koike K, Sakashita K, et al. A possible role for maternal HLA antibody in a case of alloimmune neonatal neutropenia. Transfusion. 2001 May. 41(5):615-20. [Medline].
Rezaei N, Moin M, Pourpak Z, et al. The clinical, immunohematological, and molecular study of Iranian patients with severe congenital neutropenia. J Clin Immunol. 2007 Sep. 27(5):525-33. [Medline].
Dale DC. ELANE-Related Neutropenia. 1993. [Medline].
Shim YJ, Kim HJ, Suh JS, Lee KS. Novel ELANE gene mutation in a Korean girl with severe congenital neutropenia. J Korean Med Sci. 2011 Dec. 26(12):1646-9. [Medline].
Donadieu J, Fenneteau O, Beaupain B, Mahlaoui N, Chantelot CB. Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J Rare Dis. 2011. 6:26. [Medline].
Elhassani SB. The umbilical cord: care, anomalies, and diseases. South Med J. 1984 Jun. 77(6):730-6. [Medline].
Boyle G, Rosenberg HK, O'Neill J. An unusual presentation of an infected urachal cyst. Review of urachal anomalies. Clin Pediatr (Phila). 1988 Mar. 27(3):130-4. [Medline].
Ward TT, Saltzman E, Chiang S. Infected urachal remnants in the adult: case report and review. Clin Infect Dis. 1993 Jan. 16(1):26-9. [Medline].
Masuko T, Nakayama H, Aoki N, Kusafuka T, Takayama T. Staged approach to the urachal cyst with infected omphalitis. Int Surg. 2006 Jan-Feb. 91(1):52-6. [Medline].
Kosloske AM, Bartow SA. Debridement of periumbilical necrotizing fasciitis: importance of excision of the umbilical vessels and urachal remnant. J Pediatr Surg. 1991 Jul. 26(7):808-10. [Medline].
Young TE, Mangum B. Neofax 2008. 21st edition. Thomson Reuters; 2008.
Brook I. Anaerobic infections in children. Adv Exp Med Biol. 2011. 697:117-52. [Medline].
Brook I, Dunkle LM. Anaerobic infections. McMillan J, De Angelis CD, Feigin RD, eds. Oski's Pediatrics: Principles and Practice. 3rd ed. Lippincott Williams & Wilkins; 1999. 937-50.
Gormley D. Neonatal anaerobic (clostridial) cellulitis and omphalitis. Arch Dermatol. 1977 May. 113(5):683-4. [Medline].